Allarity Therapeutics (ALLR) Misses Q3 EPS by 19c

Allarity Therapeutics (NASDAQ: ALLR) reported Q3 EPS of ($0.19).

For earnings history and earnings-related data on Allarity Therapeutics (ALLR) click here.

You May Also Be Interested In

• Oura files for 50M share IPO at $40-$44/sh
• Corbyn Lichon returns as Baldwin Insurance chief accounting officer
• Cantor on Rocket Lab USA, Inc. (RKLB): 'We remain bullish, and we view this as a good entry point'